Iceland Pharmaceutical and Medical Goods Expenditure Share (2025)
Iceland's Pharmaceutical and Medical Goods Expenditure Share: 14 % of current health expenditure in 2025, -0.5pp YoY. Eurostat (HLTH_SHA11_HC), 2005–2025.
Iceland (2025)
14
% of current health expenditure
-0.5pp YoY
YoY Change
-0.5pp
percentage points
Trend
down
Series length
21
years of data
Data
| Year | % of current health expenditure | YoY Change |
|---|---|---|
| 2025 | 14 | -0.5pp |
| 2024 | 14.5 | -0.2pp |
| 2023 | 14.7 | +1.4pp |
| 2022 | 13.3 | -0.8pp |
| 2021 | 14.1 | +0.3pp |
| 2020 | 13.8 | +0.3pp |
| 2019 | 13.5 | +0.3pp |
| 2018 | 13.2 | -0.2pp |
| 2017 | 13.4 | -0.6pp |
| 2016 | 14 | -0.9pp |
| 2015 | 14.9 | -0.4pp |
| 2014 | 15.3 | -1pp |
| 2013 | 16.3 | -1.1pp |
| 2012 | 17.4 | -0.5pp |
| 2011 | 17.9 | -0.8pp |
| 2010 | 18.7 | +0.5pp |
| 2009 | 18.2 | +1.2pp |
| 2008 | 17 | +1pp |
| 2007 | 16 | -0.5pp |
| 2006 | 16.5 | -0.2pp |
About this Dataset
Iceland recorded 14 % of current health expenditure in 2025. The latest change was -0.5pp. Across 2005–2025 the series ranges from 13.2 % of current health expenditure in 2018 to 18.7 % of current health expenditure in 2010.
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Iceland.
Data sourced from Eurostat via SDMX REST API. Values use harmonised methodology intended for cross-country comparison.
Frequently Asked Questions
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Iceland. It is published by Eurostat and updated annually.
The most recent observation covers 2025. Eurostat typically publishes this series with a lag of several months after the reference period. The series runs 2005–2025 (21 observations).
The series peaked at 18.7 % of current health expenditure in 2010 and reached its lowest recorded value of 13.2 % of current health expenditure in 2018. The latest reading is 14 % of current health expenditure in 2025. The latest change was -0.5pp.